Gemina Laboratories Ltd. (CSE:GLAB)

Canada flag Canada · Delayed Price · Currency is CAD
0.8500
-0.1200 (-12.37%)
Jun 4, 2025, 1:17 PM EDT
91.01%
Market Cap 65.09M
Revenue (ttm) n/a
Net Income (ttm) -4.07M
Shares Out 76.57M
EPS (ttm) -0.06
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 5,300
Average Volume 4,130
Open 1.0200
Previous Close 0.9700
Day's Range 0.8500 - 0.8500
52-Week Range 0.2800 - 1.2500
Beta 0.58
RSI 34.37
Earnings Date May 30, 2025

About Gemina Laboratories

Gemina Laboratories Ltd., a biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada. The company's products include LEGIO X COVID-19, a COVID-19 rapid antigen test; and LEGIO X Influenza AB, an influenza AB multiplex lateral flow test. It also develops respiratory syncytial virus and tuberculosis. Gemina Laboratories Ltd. was incorporated in 2017 and is headquartered in Burnaby, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2017
Employees 6
Stock Exchange Canadian Securities Exchange
Ticker Symbol GLAB
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.